- Home
- ENGN vs OMI Comparison
ENGN vs OMI Comparison
Compare ENGN & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- OMI
- Stock Information
- Founded
- ENGN 1999
- OMI 1882
- Country
- ENGN Canada
- OMI United States
- Employees
- ENGN N/A
- OMI N/A
- Industry
- ENGN
- OMI Medical Specialities
- Sector
- ENGN
- OMI Health Care
- Exchange
- ENGN Nasdaq
- OMI Nasdaq
- Market Cap
- ENGN 379.3M
- OMI 415.6M
- IPO Year
- ENGN N/A
- OMI N/A
- Fundamental
- Price
- ENGN $8.55
- OMI $2.83
- Analyst Decision
- ENGN Buy
- OMI Hold
- Analyst Count
- ENGN 8
- OMI 7
- Target Price
- ENGN $22.75
- OMI $7.54
- AVG Volume (30 Days)
- ENGN 3.1M
- OMI 2.1M
- Earning Date
- ENGN 12-18-2025
- OMI 10-30-2025
- Dividend Yield
- ENGN N/A
- OMI N/A
- EPS Growth
- ENGN N/A
- OMI N/A
- EPS
- ENGN N/A
- OMI N/A
- Revenue
- ENGN N/A
- OMI $10,768,859,000.00
- Revenue This Year
- ENGN N/A
- OMI N/A
- Revenue Next Year
- ENGN N/A
- OMI N/A
- P/E Ratio
- ENGN N/A
- OMI N/A
- Revenue Growth
- ENGN N/A
- OMI 132.03
- 52 Week Low
- ENGN $2.65
- OMI $2.79
- 52 Week High
- ENGN $11.14
- OMI $15.54
- Technical
- Relative Strength Index (RSI)
- ENGN 60.62
- OMI 23.89
- Support Level
- ENGN $8.14
- OMI $3.27
- Resistance Level
- ENGN $11.14
- OMI $3.13
- Average True Range (ATR)
- ENGN 0.94
- OMI 0.33
- MACD
- ENGN 0.16
- OMI -0.13
- Stochastic Oscillator
- ENGN 53.69
- OMI 0.00
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.